621 related articles for article (PubMed ID: 19059648)
21. A candidate inactivated chimeric vaccine PCV1-2 constructed based on PCV1 and PCV2 isolates originating in China and its evaluation in conventional pigs in regard to protective efficacy against PCV2 infection.
Xujie L; Xiaobo W; Yi S; Jing F; Song G; Xiufan L
Microbiol Immunol; 2011 Apr; 55(4):254-66. PubMed ID: 21244470
[TBL] [Abstract][Full Text] [Related]
22. Epitope screening of the PCV2 Cap protein by use of a random peptide-displayed library and polyclonal antibody.
Ge M; Yan A; Luo W; Hu YF; Li RC; Jiang DL; Yu XL
Virus Res; 2013 Oct; 177(1):103-7. PubMed ID: 23845304
[TBL] [Abstract][Full Text] [Related]
23. Retrospective serological survey of antibodies to porcine circovirus type 1 and type 2.
Magar R; Müller P; Larochelle R
Can J Vet Res; 2000 Jul; 64(3):184-6. PubMed ID: 10935885
[TBL] [Abstract][Full Text] [Related]
24. Enhanced replication of porcine circovirus type 2 (PCV2) in a homogeneous subpopulation of PK15 cell line.
Zhu Y; Lau A; Lau J; Jia Q; Karuppannan AK; Kwang J
Virology; 2007 Dec; 369(2):423-30. PubMed ID: 17889922
[TBL] [Abstract][Full Text] [Related]
25. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
[TBL] [Abstract][Full Text] [Related]
26. Porcine reproductive and respiratory syndrome virus as a vector: immunogenicity of green fluorescent protein and porcine circovirus type 2 capsid expressed from dedicated subgenomic RNAs.
Pei Y; Hodgins DC; Wu J; Welch SK; Calvert JG; Li G; Du Y; Song C; Yoo D
Virology; 2009 Jun; 389(1-2):91-9. PubMed ID: 19423145
[TBL] [Abstract][Full Text] [Related]
27. Antigenic properties of porcine teschovirus 1 (PTV-1) Talfan strain and molecular strategy for serotyping of PTVs.
Kaku Y; Murakami Y; Sarai A; Wang Y; Ohashi S; Sakamoto K
Arch Virol; 2007; 152(5):929-40. PubMed ID: 17265104
[TBL] [Abstract][Full Text] [Related]
28. Amino acid mutations in the capsid protein produce novel porcine circovirus type 2 neutralizing epitopes.
Liu J; Huang L; Wei Y; Tang Q; Liu D; Wang Y; Li S; Guo L; Wu H; Liu C
Vet Microbiol; 2013 Aug; 165(3-4):260-7. PubMed ID: 23582511
[TBL] [Abstract][Full Text] [Related]
29. Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs.
Pérez-Martín E; Grau-Roma L; Argilaguet JM; Nofrarías M; Escribano JM; Gómez-Sebastián S; Segalés J; Rodríguez F
J Virol Methods; 2008 Dec; 154(1-2):167-74. PubMed ID: 18773923
[TBL] [Abstract][Full Text] [Related]
30. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
[TBL] [Abstract][Full Text] [Related]
31. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
32. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins.
Fort M; Sibila M; Allepuz A; Mateu E; Roerink F; Segalés J
Vaccine; 2008 Feb; 26(8):1063-71. PubMed ID: 18237827
[TBL] [Abstract][Full Text] [Related]
33. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
[TBL] [Abstract][Full Text] [Related]
34. Early antibody responses map to non-protective, PCV2 capsid protein epitopes.
Ilha M; Nara P; Ramamoorthy S
Virology; 2020 Jan; 540():23-29. PubMed ID: 31734380
[TBL] [Abstract][Full Text] [Related]
35. Utilization of phage display to identify antigenic regions in the PCV2 capsid protein for the evaluation of serological responses in mice and pigs.
Santos MR; Assao VS; Santos FAA; Salgado RL; Carneiro AP; Fietto JLR; Bressan GC; de Almeida MR; Lobato ZIP; Ueira-Veira C; Goulart LR; Silva-Júnior A
Arch Virol; 2018 Jul; 163(7):1877-1887. PubMed ID: 29589172
[TBL] [Abstract][Full Text] [Related]
36. Characterization and potential use of truncated PCV2 capsid protein and its polyclonal antibody for diagnosis of PCV2 infections.
Shuai J; Li X; Chen N; Chen X; Fang W
Wei Sheng Wu Xue Bao; 2008 Jan; 48(1):85-90. PubMed ID: 18338582
[TBL] [Abstract][Full Text] [Related]
37. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs.
Fort M; Olvera A; Sibila M; Segalés J; Mateu E
Vet Microbiol; 2007 Dec; 125(3-4):244-55. PubMed ID: 17611048
[TBL] [Abstract][Full Text] [Related]
38. Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses.
Kekarainen T; Montoya M; Dominguez J; Mateu E; Segalés J
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):41-9. PubMed ID: 18304652
[TBL] [Abstract][Full Text] [Related]
39. [Construction of infectious DNA clone of chimeric porcine circovirus type 1-2 and its immunogenicity in mice].
Yi S; Lina Z; Song G; Xiufan L
Wei Sheng Wu Xue Bao; 2008 Sep; 48(9):1234-40. PubMed ID: 19062650
[TBL] [Abstract][Full Text] [Related]
40. Infection studies on human cell lines with porcine circovirus type 1 and porcine circovirus type 2.
Hattermann K; Roedner C; Schmitt C; Finsterbusch T; Steinfeldt T; Mankertz A
Xenotransplantation; 2004 May; 11(3):284-94. PubMed ID: 15099209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
